PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
09-Nov-2020 New XARELTO® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020 Janssen Pharmaceutical Companies of Johnson & Johnson
09-Nov-2020 MEI Pharma to Present at Two Upcoming Investor Healthcare Conferences MEI Pharma, Inc.
09-Nov-2020 Amgen Presents First Clinical Data for AMG 757 at SITC 2020 Amgen
09-Nov-2020 OncoHost to Present Data on Predicting Host Response to Immunotherapy in Melanoma Patients at SITC 2020 OncoHost
09-Nov-2020 DTx Pharma Announces Appointment of Denise Bevers as Chief Operating Officer DTx Pharma
09-Nov-2020 Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics Merck
09-Nov-2020 FDA Grants Rare Pediatric Disease Designation to AMO Pharma for AMO-02 for Treatment of Congenital Myotonic Dystrophy AMO Pharma Limited
09-Nov-2020 Pliant Therapeutics to Present Data at The Liver Meeting® 2020 Pliant Therapeutics, Inc.
09-Nov-2020 FDA Grants Rare Pediatric Disease Designation to AMO Pharma for AMO-02 for Treatment of Congenital Myotonic Dystrophy AMO Pharma Limited
09-Nov-2020 CARISMA to Present New Data at The Society for Immunotherapy of Cancer 35th Anniversary Annual Meeting CARISMA Therapeutics Inc.
09-Nov-2020 Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer Treatment Phio Pharmaceuticals Corp.
09-Nov-2020 Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Expert Oncologist Panel During 2020 Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting Nektar Therapeutics
09-Nov-2020 BioSpecifics Reports Third Quarter 2020 Financial and Operating Results BioSpecifics Technologies Corp.
09-Nov-2020 CNS Pharmaceuticals Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be Submitted for FDA Review CNS Pharmaceuticals, Inc.
09-Nov-2020 Prometheus Biosciences Announces $130 Million Financing to Advance Precision Medicines for the Treatment of Inflammatory Bowel Disease Prometheus Biosciences, Inc.
09-Nov-2020 OncoHost to Present Data on Predicting Host Response to Immunotherapy in Melanoma Patients at SITC 2020 OncoHost
09-Nov-2020 Registration is now open for SMi’s 15th Annual Parallel Trade Conference 2021 SMi Group Ltd
09-Nov-2020 HRA Pharma appoints OTC Medical as distributor in the Netherlands in a bid to expand further in the Dutch market HRA Pharma
09-Nov-2020 BioMed X Institute Announces Expansion of their Strategic Collaboration with Janssen in Immunology Research B3C newswire
09-Nov-2020 APEIRON Biologics AG and Domainex Ltd announce the expansion of their partnership to progress targeted cancer immune therapy drug discovery APEIRON Biologics AG